Anemia and the Chronic Hyperadrenergic State following Major Trauma

$256,500R01FY2015GMNIH

University Of Florida, Gainesville FL

Investigators

Linked publications & trials

Paper 39178199 Paper 38860566 Paper 38480488 Paper 38151766 Paper 37853556 Paper 37804796 Paper 37310788 Paper 36959585 Paper 36872509 Paper 36772985 Paper 36727772 Paper 36652391 Paper 36203239 Paper 35672167 Paper 35593749 Paper 35514362 Paper 34958257 Paper 34506322 Paper 34361995 Paper 34252063 Paper 34186308 Paper 34172608 Paper 34144563 Paper 33920518 Paper 33413921 Paper 33373851 Paper 33234838 Paper 33140449 Paper 33021571 Paper 32826817 Paper 32769953 Paper 32741547 Paper 32381107 Paper 32294254 Paper 31904616 Paper 31881381 Paper 31856021 Paper 31825465 Paper 31672639 Paper 31378316 Paper 31207479 Paper 30991107 Paper 30827533 Paper 30562327 Paper 30509454 Paper 30489504 Paper 30225563 Paper 29960715 Paper 29937004 Paper 29807651 Paper 29768025 Paper 29670613 Paper 29468579 Paper 29466280 Paper 29370051 Paper 29307734 Paper 29146455 Paper 29140948 Paper 29035909 Paper 28837537 Paper 28720216 Paper 28666582 Paper 28624051 Paper 28550920 Paper 28457321 Paper 28457316 Paper 28452894 Paper 28426559 Paper 28409378 Paper 28231518 Paper 28115287 Paper 28099381 Paper 28099380 Paper 28050668 Paper 28009772 Paper 27893641 Paper 27787442 Paper 27779592 Paper 27742030 Paper 27635693 Paper 27632674 Paper 27398985 Paper 27172161 Paper 27163951 Paper 26830071 Paper 26578697 Paper 26402534 Paper 26246141 Paper 26209570 Paper 26091320 Paper 26079230 Paper 26034205

Abstract

DESCRIPTION (provided by applicant): Patients suffering major trauma and critical illness develop an injury-associated persistent anemia which is not related to acute blood loss. Understanding the pathophysiology of this persistent anemia would avoid the use of blood transfusions which is currently the only available treatment. Our overall goal is to develop treatment strategies for this persistent anemia. Injury and hemorrhagic shock worsen bone marrow (BM) dysfunction and inhibit the differentiation of hematopoietic progenitor cells (HPC) and lead to increased mobilization of HPC from the BM to the peripheral blood and sites of injury. Our recent studies suggest that this BM dysfunction is linked to a hyperadrenergic state and that with critical illness this hyperadrenergic state is prolonged. This proposal will test the central hypothesis that chronic adrenergic stimulation following injury and hemorrhagic shock worsens BM dysfunction further inhibiting the differentiation of HPCs and exaggerating the mobilization of HPCs from BM contributing to injury-associated persistent anemia. Our specific aims are to: Aim 1. Determine the effects of a persistent inflammatory milieu on BM erythroid differentiation and anemia. Aim 2. Determine if excessive and ongoing HPC mobilization contributes to persistent anemia. These aims will be examined in our established model of lung contusion and hemorrhagic shock followed by daily restraint to simulated chronic stress. To compliment both these aims we will also examine the use of beta adrenergic blockade and 6-hydroxydopamine to decrease the hyperadrenergic state and prevent BM dysfunction and thus alleviate persistent anemia.

View original record on NIH RePORTER →